| EPLBF07 | Advancing HIV prevention research in pregnant and breastfeeding populations (PBFP): priority advocacy objectives and next steps | E-poster | Inclusion considerations for research and development and other trials |
| EPLBF08 | The Brazilian response to HIV/AIDS & COVID-19: double standards and rights violations | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| PEMOD66 | 'Impact of coronavirus disease 2019 social distancing and curfews on the people of western Uganda: implications for access to HIV care | E-poster | COVID-19 social distancing and curfews: Implications for access to HIV care |
| EPA037 | MVA/Protein HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques | E-poster | Novel vectors, adjuvants and strategies |
| EPA062 | Gamma/Delta T cells target latently HIV-infected non-T cell reservoirs | E-poster | Strategies to reduce/eliminate viral reservoirs |
| EPB027 | Diagnostic performance of HbA1c, fasting blood glucose, and the oral glucose tolerance test among people with HIV | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB106 | Non-alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV | E-poster | Other non-communicable diseases |
| EPC098 | Comprehensive clinical care disruption for criminally-justice involved people living with HIV following implementation of Shelter-in-Place and decarceration | E-poster | Surveillance of HIV in key populations |
| EPC216 | Outcomes of a pharmacist-led, same-day pre-exposure prophylaxis (PrEP) program in Mississippi: a mixed-methods study | E-poster | Scale up of PrEP |
| EPD150 | HIV- and prevention-related knowledge and beliefs, HIV testing, and condom use in a school-based sample of 6,000 Rwandan adolescents | E-poster | Young key populations |